Trial intelligence / Profile preview

Effectiveness of 5% calendula extract cream versus 1% silver sulfadiazine cream in pressure ulcer wound healing

TCTR20251016003Phase 2Active, not recruiting

Sponsor
Thailand Science Research and Innovation
Start
Nov 2024
Countries
1
01

Overview

A Phase 2 trial of calendula officinalis extract in decubitus ulcer, sponsored by Thailand Science Research and Innovation. Started Nov 2024; status: active, not recruiting.

02

Drugs

calendula officinalis extract
03

Conditions

decubitus ulcer

Beyond the preview

Go deeper on TCTR20251016003.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20251016003.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call